Author: Ramaswamy, Swathi Beladakere; Govindarajan, Raghav
Title: COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome Cord-id: svgknqud Document date: 2020_6_2
ID: svgknqud
Snippet: This is a brief report of a patient who has refractory Myasthenia Gravis, on multiple long-term immunosuppressive therapies and contracted COVID-19 during this 2020 pandemic. She was quarantined for total of 14 days and recovered successfully without any complications (no myasthenia exacerbation or crisis, no COVID-19 related complications), with no changes to her immunosuppressive therapy. Treatment of MG patients with COVID-19 needs to be tailored to individual patient.
Document: This is a brief report of a patient who has refractory Myasthenia Gravis, on multiple long-term immunosuppressive therapies and contracted COVID-19 during this 2020 pandemic. She was quarantined for total of 14 days and recovered successfully without any complications (no myasthenia exacerbation or crisis, no COVID-19 related complications), with no changes to her immunosuppressive therapy. Treatment of MG patients with COVID-19 needs to be tailored to individual patient.
Search related documents:
Co phrase search for related documents- acetylcholine receptor antibody and achr acetylcholine receptor: 1
Co phrase search for related documents, hyperlinks ordered by date